| scholarly article | Q13442814 |
| review article | Q7318358 |
| P50 | author | Andrew J. Tatem | Q29397317 |
| Ricardo J Soares Magalhaes | Q42872526 | ||
| Archie Clements | Q56561190 | ||
| David L Paterson | Q59993174 | ||
| P2093 | author name string | Thomas V Riley | |
| P2860 | cites work | Clostridium difficile ribotype 027-associated disease in children with norovirus infection | Q84302002 |
| Epidemic Clostridium difficile | Q95796618 | ||
| Epidemic Clostridium difficile | Q95796632 | ||
| Bacteriological evaluation of commercial canine and feline raw diets. | Q24529054 | ||
| Clostridium difficile infection in patients discharged from US short-stay hospitals, 1996-2003 | Q24627863 | ||
| The challenges posed by reemerging Clostridium difficile infection | Q30229530 | ||
| Introduction to animal antimicrobial use data collection in the United States: methodological options | Q31016422 | ||
| Deliberations of an Advisory Committee regarding priorities, sources, and methods for collecting animal antimicrobial use data in the United States | Q31019180 | ||
| Overview of issues pertaining to the manufacture, distribution, and use of antimicrobials in animals and other information relevant to animal antimicrobial use data collection in the United States | Q31019620 | ||
| Clostridium difficile ribotype 027, toxinotype III, the Netherlands | Q33243642 | ||
| Aerial dissemination of Clostridium difficile spores | Q33316379 | ||
| Chikungunya virus infection in travellers to Australia | Q33378327 | ||
| Survey of incidence of Clostridium difficile infection in Canadian hospitals and diagnostic approaches. | Q33673934 | ||
| Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. | Q33800946 | ||
| Molecular epidemiology of endemic Clostridium difficile infection and the significance of subtypes of the United Kingdom epidemic strain (PCR ribotype 1) | Q33856234 | ||
| Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec | Q33990521 | ||
| Clostridium difficile and the aetiology of pseudomembranous colitis | Q34058811 | ||
| Quantitative risk assessment of human listeriosis from consumption of soft cheese made from raw milk | Q34068228 | ||
| Mortality attributable to nosocomial Clostridium difficile-associated disease during an epidemic caused by a hypervirulent strain in Quebec | Q34099215 | ||
| Antibiotics and hospital-acquired Clostridium difficile-associated diarrhoea: a systematic review. | Q34196731 | ||
| Fluoroquinolone use and Clostridium difficile-associated diarrhea. | Q34202065 | ||
| Outpatient antibiotic use in Europe and association with resistance: a cross-national database study | Q34393751 | ||
| Mathematical modeling of Clostridium difficile infection | Q34395315 | ||
| Fluoroquinolone prescribing in the United States: 1995 to 2002. | Q34399799 | ||
| Risk factors for acquisition of Clostridium difficile-associated diarrhea among outpatients at a cancer hospital | Q34450149 | ||
| Severe Clostridium difficile-associated disease in populations previously at low risk--four states, 2005. | Q34471684 | ||
| A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality | Q34472139 | ||
| An epidemic, toxin gene-variant strain of Clostridium difficile | Q34472146 | ||
| The first case of antibiotic-associated colitis by Clostridium difficile PCR ribotype 027 in Korea | Q34609154 | ||
| Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents | Q34690415 | ||
| Molecular analysis of Clostridium difficile PCR ribotype 027 isolates from Eastern and Western Canada | Q34719551 | ||
| Clostridium difficile among hospitalized patients receiving antibiotics: a case-control study | Q43407358 | ||
| First cluster of C. difficile toxinotype III, PCR-ribotype 027 associated disease in France: preliminary report. | Q43547079 | ||
| Community acquired Clostridium difficile infection due to a moxifloxacin susceptible ribotype 027 strain | Q43585941 | ||
| Emergence of Clostridium difficile toxinotype III, PCR-ribotype 027-associated disease, France, 2006. | Q43587868 | ||
| Outbreak of Clostridium difficile 027 infection in Vienna, Austria 2008-2009. | Q43624772 | ||
| Prospective evaluation of environmental contamination by Clostridium difficile in isolation side rooms | Q43707037 | ||
| First isolation of Clostridium difficile PCR ribotype 027 in Finland | Q43963265 | ||
| Recurrent infection with epidemic Clostridium difficile in a peripartum woman whose infant was asymptomatically colonized with the same strain | Q44036561 | ||
| First isolation of Clostridium difficile 027 in Japan | Q44368857 | ||
| Spatio-temporal stochastic modelling of Clostridium difficile | Q44413851 | ||
| Clostridium difficile: prevalence in horses and environment, and antimicrobial susceptibility. | Q44521854 | ||
| A European survey of diagnostic methods and testing protocols for Clostridium difficile | Q44655220 | ||
| Risk factors and mortality associated with Clostridium difficile-associated diarrhoea at a VA hospital | Q45157531 | ||
| Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system | Q45332183 | ||
| A variety of respiratory viruses found in symptomatic travellers returning from countries with ongoing spread of the new influenza A(H1N1)v virus strain | Q45383327 | ||
| A survey of agents associated with neonatal diarrhea in Iowa swine including Clostridium difficile and porcine reproductive and respiratory syndrome virus | Q45731518 | ||
| Surveillance for community-associated Clostridium difficile--Connecticut, 2006. | Q45915397 | ||
| First Australian isolation of epidemic Clostridium difficile PCR ribotype 027. | Q45968820 | ||
| Outbreak of Clostridium difficile 027 in North Zealand, Denmark, 2008-2009. | Q46039069 | ||
| Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. | Q46353482 | ||
| A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. | Q46408982 | ||
| First cluster of clindamycin-resistant Clostridium difficile PCR ribotype 027 in Switzerland. | Q46654982 | ||
| Clostridium difficile--associated disease in a setting of endemicity: identification of novel risk factors | Q46812258 | ||
| Antimicrobial resistance: risk analysis methodology for the potential impact on public health of antimicrobial resistant bacteria of animal origin | Q50119637 | ||
| Incidence and impact of Clostridium difficile infection in the UK, 1993-1996. | Q50633256 | ||
| Varying rates of Clostridium difficile-associated diarrhea at prevention epicenter hospitals. | Q50769155 | ||
| Experience of Severe Acute Respiratory Syndrome in Singapore: Importation of Cases, and Defense Strategies at the Airport | Q51649985 | ||
| Equine colitis X associated with infection by Clostridium difficile NAP1/027. | Q34978636 | ||
| Clostridium difficile-associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity | Q35874779 | ||
| The emergence of Clostridium difficile as a pathogen of food animals | Q36177434 | ||
| Guidelines for prudent use of antimicrobials and their implications on antibiotic usage in veterinary medicine | Q36415011 | ||
| Increased sporulation rate of epidemic Clostridium difficile Type 027/NAP1 | Q36539739 | ||
| Epidemiology, pathogenesis, and management of Clostridium difficile infection | Q36778849 | ||
| Clostridium difficile infections in a Canadian tertiary care hospital before and during a regional epidemic associated with the BI/NAP1/027 strain. | Q36870734 | ||
| Increase in adult Clostridium difficile-related hospitalizations and case-fatality rate, United States, 2000-2005 | Q37009233 | ||
| Clostridium difficile in ready-to-eat salads, Scotland | Q37203796 | ||
| Clostridium difficile in retail meat products, USA, 2007 | Q37203800 | ||
| Peripartum Clostridium difficile infection: case series and review of the literature | Q37221075 | ||
| Clostridium difficile in food--innocent bystander or serious threat? | Q37651083 | ||
| Possible seasonality of Clostridium difficile in retail meat, Canada | Q38437040 | ||
| Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis | Q38537810 | ||
| In vitro susceptibility of Clostridium difficile clinical isolates from a multi-institutional outbreak in Southern Québec, Canada | Q38665033 | ||
| Quantitative assessment of the likelihood of the introduction of classical swine fever virus into the Danish swine population | Q38922179 | ||
| Multiple outbreaks of dengue serotype 2 in north Queensland, 2003/04. | Q39044708 | ||
| An outbreak of Plasmodium vivax malaria in Far North Queensland, 2002. | Q39044725 | ||
| Chikungunya infection in a French traveller returning from the Maldives, October, 2009. | Q39388346 | ||
| Clinical and molecular epidemiology of sporadic and clustered cases of nosocomial Clostridium difficile diarrhea | Q39419199 | ||
| Underlying disease severity as a major risk factor for nosocomial Clostridium difficile diarrhea | Q39636517 | ||
| Evaluation of Clostridium difficile-associated disease pressure as a risk factor for C difficile-associated disease | Q40209068 | ||
| Clinical features of Clostridium difficile-associated infections and molecular characterization of strains: results of a retrospective study, 2000-2004. | Q40458839 | ||
| Prevalence of PCR ribotypes among Clostridium difficile isolates from pigs, calves, and other species | Q42119119 | ||
| Detection and enumeration of Clostridium difficile spores in retail beef and pork | Q42152233 | ||
| Clostridium difficile PCR ribotypes in calves, Canada | Q42196807 | ||
| Clostridium difficile in retail ground meat, Canada | Q42260778 | ||
| Increase in deaths related to enterocolitis due to Clostridium difficile in the United States, 1999-2002. | Q42416659 | ||
| C. difficile may have killed 2000 in Quebec: study | Q42590755 | ||
| Clostridium difficile in discharged inpatients, Germany | Q42611280 | ||
| Epidemic Clostridium difficile strain in hospital visitation dog. | Q42651416 | ||
| Emergence of Clostridium difficile NAP1 in Latin America. | Q42924473 | ||
| Need for national surveillance for hospital infections | Q43130858 | ||
| Ontario's hospitals surpass those of Quebec in C. difficile rates | Q43190610 | ||
| Prevalence of zoonotic agents in dogs visiting hospitalized people in Ontario: implications for infection control | Q43219913 | ||
| A human health risk assessment for macrolide-resistant Campylobacter associated with the use of macrolides in Danish pig production | Q43222903 | ||
| Clindamycin-resistant clone of Clostridium difficile PCR Ribotype 027, Europe | Q43227675 | ||
| First isolation of Clostridium difficile PCR ribotype 027 from a patient with severe persistent diarrhoea in Hungary | Q43287161 | ||
| Clostridium difficile in a geriatric unit: a prospective epidemiological study employing a novel S-layer typing method | Q43364102 | ||
| Climatic similarity and biological exchange in the worldwide airline transportation network. | Q51710666 | ||
| A hospital outbreak of diarrhea due to an emerging epidemic strain of Clostridium difficile. | Q51926961 | ||
| Confirmed cases and report of clusters of severe infections due to Clostridium difficile PCR ribotype 027 in Germany. | Q52922190 | ||
| Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. | Q53232557 | ||
| Decrease of hypervirulent Clostridium difficile PCR ribotype 027 in the Netherlands. | Q54452855 | ||
| First cases of Clostridium difficile PCR ribotype 027 acquired in Austria. | Q54517715 | ||
| Update of Clostridium difficile infection due to PCR ribotype 027 in Europe, 2008. | Q54517725 | ||
| Laboratory diagnosis of Clostridium difficile-associated disease in the Republic of Ireland: a survey of Irish microbiology laboratories. | Q54541309 | ||
| Epidemiology of Clostridium difficile toxinotype III, PCR-ribotype 027 associated disease in Belgium, 2006. | Q54573576 | ||
| Clostridium difficile ribotype 027 arrives in Hong Kong | Q56767871 | ||
| Evaluation of Clostridium difficile in dogs and the household environment | Q56771061 | ||
| Health Care–AssociatedClostridium difficileInfection in Canada: Patient Age and Infecting Strain Type Are Highly Predictive of Severe Outcome and Mortality | Q57660905 | ||
| Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe | Q58924160 | ||
| Spread and Epidemiology of Clostridium difficile Polymerase Chain Reaction Ribotype 027/Toxinotype III in The Netherlands | Q59361760 | ||
| Prospective study of Clostridium difficile infections in Europe with phenotypic and genotypic characterisation of the isolates | Q59688382 | ||
| Update of Clostridium difficile-associated disease due to PCR ribotype 027 in Europe | Q60530806 | ||
| Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains | Q61708585 | ||
| Clostridium difficile–associated diarrhea: an emerging threat to pregnant women | Q61714811 | ||
| Per capita antibiotic consumption: how does a North American jurisdiction compare with Europe? | Q64133493 | ||
| First confirmed cases of Clostridium difficile PCR ribotype 027 in Norway. | Q64941847 | ||
| Risk factors for Clostridium difficile carriage and C. difficile-associated diarrhea in a cohort of hospitalized patients | Q68890738 | ||
| Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations | Q70794622 | ||
| The role of physical proximity in nosocomial diarrhea | Q73037900 | ||
| Antibiotic-associated diarrhoea and Clostridium difficile in the community | Q73172352 | ||
| Typhlocolitis caused by Clostridium difficile in suckling piglets | Q74396940 | ||
| Clostridium difficile colitis: an increasingly aggressive iatrogenic disease? | Q78318477 | ||
| Molecular analysis of Clostridium difficile isolates recovered from horses with diarrhea | Q79368408 | ||
| Clostridium difficile-associated disease in Oregon: increasing incidence and hospital-level risk factors | Q79694803 | ||
| Moxifloxacin therapy as a risk factor for Clostridium difficile-associated disease during an outbreak: attempts to control a new epidemic strain | Q79694839 | ||
| Outbreak of Clostridium difficile infection in an English hospital linked to hypertoxin-producing strains in Canada and the US | Q79749047 | ||
| Isolation of Clostridium difficile ribotype 027, toxinotype III in the Netherlands after increase in C. difficile-associated diarrhoea | Q79755221 | ||
| First isolation of Clostridium difficile PCR ribotype 027, toxinotype III in Belgium | Q79767224 | ||
| A case of Clostridium difficile-associated disease due to the highly virulent clone of Clostridium difficile PCR ribotype 027, March 2007 in Germany | Q79840787 | ||
| Secular trends in hospital-acquired Clostridium difficile disease in the United States, 1987-2001 | Q80020959 | ||
| National Clostridium difficile Standards Group: Report to the Department of Health | Q80057993 | ||
| Epidemic Clostridium difficile | Q80069532 | ||
| Molecular analysis of Clostridium difficile at a university teaching hospital in Japan: a shift in the predominant type over a five-year period | Q80657875 | ||
| Deaths involving Clostridium difficile: England and Wales, 1999 and 2001-06 | Q80898979 | ||
| First isolation and report of clusters of Clostridium difficile PCR 027 cases in Ireland | Q81296040 | ||
| PCR ribotyping of Clostridium difficile isolates originating from human and animal sources | Q81325169 | ||
| Changing epidemiology of Clostridium difficile-associated disease in children | Q81416962 | ||
| Clostridium difficile: a questionnaire survey of laboratory practice in England, Wales, and Northern Ireland | Q81549695 | ||
| First report of hypervirulent strains polymerase chain reaction ribotypes 027 and 078 causing severe Clostridium difficile infection in Italy | Q82205916 | ||
| P433 | issue | 6 | |
| P921 | main subject | Clostridium difficile | Q310543 |
| P1104 | number of pages | 10 | |
| P304 | page(s) | 395-404 | |
| P577 | publication date | 2010-06-01 | |
| P1433 | published in | Lancet Infectious Diseases | Q15724248 |
| P1476 | title | Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread | |
| P478 | volume | 10 |
| Q63230054 | 2019 update of the WSES guidelines for management of () infection in surgical patients |
| Q35677616 | A modified R-type bacteriocin specifically targeting Clostridium difficile prevents colonization of mice without affecting gut microbiota diversity |
| Q39587051 | A prospective cohort study on hospital mortality due to Clostridium difficile infection |
| Q42110626 | Activity of a novel cyclic lipopeptide, CB-183,315, against resistant Clostridium difficile and other Gram-positive aerobic and anaerobic intestinal pathogens |
| Q34737651 | Antimicrobial susceptibilities and molecular epidemiology of clinical isolates of Clostridium difficile in taiwan |
| Q33834926 | Assessing control bundles for Clostridium difficile: a review and mathematical model |
| Q28083860 | Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications |
| Q27009228 | Bacteriotherapy for the treatment of intestinal dysbiosis caused by Clostridium difficile infection |
| Q42248359 | Bed occupancy rates and hospital-acquired Clostridium difficile infection: a cohort study |
| Q37545356 | Carriage of Clostridium difficile by wild urban Norway rats (Rattus norvegicus) and black rats (Rattus rattus). |
| Q37125211 | Challenges for standardization of Clostridium difficile typing methods |
| Q33916437 | Clinical Clostridium difficile: clonality and pathogenicity locus diversity |
| Q34263649 | Clinical and microbiologic characteristics of tcdA-negative variant Clostridium difficile infections |
| Q33759832 | Clostridium difficile Infection: Epidemiology, Pathogenesis, Risk Factors, and Therapeutic Options |
| Q31108764 | Clostridium difficile Infections amongst Patients with Haematological Malignancies: A Data Linkage Study |
| Q53692769 | Clostridium difficile Infections: A Global Overview of Drug Sensitivity and Resistance Mechanisms. |
| Q34943390 | Clostridium difficile exposure as an insidious source of infection in healthcare settings: an epidemiological model |
| Q45354724 | Clostridium difficile healthcare-associated epidemics |
| Q38074514 | Clostridium difficile in foods and animals: history and measures to reduce exposure |
| Q60500782 | Clostridium difficile infection |
| Q37289567 | Clostridium difficile infection in the twenty-first century |
| Q35182396 | Clostridium difficile infection seasonality: patterns across hemispheres and continents - a systematic review |
| Q37814046 | Clostridium difficile infection: epidemiology, risk factors and management |
| Q35317777 | Clostridium difficile isolates with increased sporulation: emergence of PCR ribotype 002 in Hong Kong. |
| Q34988747 | Clostridium difficile--a moving target |
| Q46793647 | Community-acquired infection with hypervirulent Clostridium difficile isolates that carry different toxin and antibiotic resistance loci: a case report. |
| Q38592679 | Dentists, antibiotics and Clostridium difficile-associated disease |
| Q36306533 | Determining Clostridium difficile intra-taxa diversity by mining multilocus sequence typing databases. |
| Q28084700 | Diversity and Evolution in the Genome of Clostridium difficile |
| Q38824193 | Effect of passive immunotherapy against Clostridium difficile infection: a systematic review and meta-analysis |
| Q34306091 | Efficacy and safety of fidaxomicin compared with oral vancomycin for the treatment of adults with Clostridium difficile-associated diarrhea: data from the OPT-80-003 and OPT-80-004 studies |
| Q36708973 | Emergence and global spread of epidemic healthcare-associated Clostridium difficile |
| Q41195681 | Emergence and spread of predominantly community-onset Clostridium difficile PCR ribotype 244 infection in Australia, 2010 to 2012. |
| Q36997707 | Emergence of Clostridium difficile infection in tuberculosis patients due to a highly rifampicin-resistant PCR ribotype 046 clone in Poland |
| Q37033281 | Epidemiology of Clostridium difficile infection in Asia |
| Q64119312 | Epidemiology of Clostridium difficile infection in hospitalized adults and the first isolation of C. difficile PCR ribotype 027 in central China |
| Q41592976 | Evidence of in vivo prophage induction during Clostridium difficile infection. |
| Q39395831 | Fecal microbiota transplantation for recurrent clostridium difficile infection in children. |
| Q34827720 | Fecal transplant policy and legislation |
| Q38107547 | Fidaxomicin for treatment of clostridium difficile-associated diarrhea and its potential role for prophylaxis. |
| Q33641301 | Functional genomics reveals that Clostridium difficile Spo0A coordinates sporulation, virulence and metabolism |
| Q34062256 | Hypervirulent Clostridium difficile PCR-ribotypes exhibit resistance to widely used disinfectants |
| Q91828465 | Incidence Of Clostridium difficile Infection And Associated Risk Factors Among Hospitalized Children In Qatar |
| Q39665226 | Lack of association between clinical outcome of Clostridium difficile infections, strain type, and virulence-associated phenotypes |
| Q90451041 | Mechanism of Antibacterial Activity of Bacillus amyloliquefaciens C-1 Lipopeptide toward Anaerobic Clostridium difficile |
| Q61805736 | Modeling Clostridium difficile in a hospital setting: control and admissions of colonized and symptomatic patients |
| Q50023348 | New Insights into Clostridium difficile (CD) Infection in Latin America: Novel Description of Toxigenic Profiles of Diarrhea-Associated to CD in Bogotá, Colombia |
| Q42110052 | Nontoxigenic Clostridium difficile protects hamsters against challenge with historic and epidemic strains of toxigenic BI/NAP1/027 C. difficile |
| Q36076316 | Nosocomial transmission of Clostridium difficile ribotype 027 in a Chinese hospital, 2012-2014, traced by whole genome sequencing |
| Q35862915 | Novel approaches to treating Clostridium difficile-associated colitis. |
| Q38632664 | Novel therapeutic strategies for Clostridium difficile infections |
| Q40579622 | Probiotic Saccharomyces boulardii CNCM I-745 prevents outbreak-associated Clostridium difficile-associated cecal inflammation in hamsters |
| Q45014859 | Progress toward developing a carbohydrate-conjugate vaccine against Clostridium difficile ribotype 027: synthesis of the cell-surface polysaccharide PS-I repeating unit |
| Q26767079 | Recent advances in the understanding of antibiotic resistance in Clostridium difficile infection |
| Q90149625 | Risk factors and treatment outcomes of severe Clostridioides difficile infection in Singapore |
| Q33729925 | Risk factors for recurrent Clostridium difficile infection (CDI) hospitalization among hospitalized patients with an initial CDI episode: a retrospective cohort study |
| Q35035736 | Sequence variation in tcdA and tcdB of Clostridium difficile: ST37 with truncated tcdA is a potential epidemic strain in China |
| Q34468946 | Targeted restoration of the intestinal microbiota with a simple, defined bacteriotherapy resolves relapsing Clostridium difficile disease in mice |
| Q92458338 | The use and reporting of airline passenger data for infectious disease modelling: a systematic review |
| Q34710368 | Treatment of Clostridium difficile infection: recent trial results |
| Q83748792 | Underestimation of Clostridium difficile infection among clinicians: an international survey |
| Q36765251 | Using machine-learned bayesian belief networks to predict perioperative risk of clostridium difficile infection following colon surgery |
| Q92616883 | Virulence Factors of Clostridioides (Clostridium) difficile Linked to Recurrent Infections |
| Q26795429 | WSES guidelines for management of Clostridium difficile infection in surgical patients |
Search more.